News tagged with drug warfarin
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
Newly approved blood thinner may increase susceptibility to some viral infections
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral ...
Medical research
Apr 01, 2013 |
not rated yet |
0
|
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Bristol-Myers, Pfizer's Eliquis approved in Japan
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications
Dec 26, 2012 |
not rated yet |
0
FDA: Pradaxa not for patients with mechanical heart valves
(HealthDay)—The blood thinner Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves, the U.S. Food and Drug Administration said in a warning issued Wednesday.
Cardiology
Dec 21, 2012 |
not rated yet |
0
New blood thinner may help prevent leg clots, study finds
(HealthDay)—The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.
Medications
Dec 10, 2012 |
5 / 5 (3) |
0
|
Undertreatment of common heart condition persists despite rapid adoption of novel therapies
A novel blood thinner recently approved by the FDA, dabigatran (Pradaxa), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation. This is according ...
Cardiology
Sep 21, 2012 |
not rated yet |
0
Quick-reversal method may be at hand for new blood thinner
(HealthDay) -- Newer blood-thinning drugs sometimes have one drawback: In cases where they trigger bleeding, their effects can be tough to reverse compared to the standard anticoagulant, warfarin.
Medications
Jun 20, 2012 |
not rated yet |
0
|
New blood thinner may lower chances of clots in high-risk heart patients: FDA
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
Medications
May 21, 2012 |
not rated yet |
0
Clot-busting drug safe for stroke patients taking blood thinner
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...
Cardiology
May 10, 2012 |
5 / 5 (1) |
0
Stroke risk high when anti-clotting drugs stopped
Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...
Cardiology
Apr 25, 2012 |
not rated yet |
0
Stroke-preventing technology demonstrated in JoVE
In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million ...
Cardiology
Feb 28, 2012 |
not rated yet |
0
Study finds warfarin underutilized in women
Dr. Rabab Mohsin, an internal medicine resident at the University of Kentucky, working with Dr. Alison Bailey of the University of Kentucky Gill Heart Institute, has discovered that the drug warfarin was underutilized in ...
Medications
Dec 13, 2011 |
not rated yet |
0
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in ...
Medical research
Aug 28, 2011 |
5 / 5 (3) |
1
|
Study shows ability of new agent to prevent strokes in patients with atrial fibrillation
In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting ...
Cardiology
Aug 10, 2011 |
3 / 5 (1) |
0
